JAMES WOODY

Profile

First Name

: JAMES

Middle Name

:

Last Name

: WOODY

Related Companies
Titles
Company Name
Related People
DIRECTOR
CELL BIOSCIENCES INC
DAVID BARKER, JAMES BLAIR, A. BLAINE BOWMAN, RON EASTMAN, JULIE ESKAY-EAGLE, TIMOTHY HARKNESS, JACK NIELSON, JAMES NOVI, JASON NOVI
DIRECTOR
TETRALOGIC PHARMACEUTICALS CORP
BRENDA GAVIN, JOHN M. GILL, JAMES E. GOLDSCHMIDT, HELGA KAUTSKY, JACK LASERSOHN, MARK A. MCKINLAY, GEORGE MCLENDON, DOUGLAS ONSI, ANDREW PECORA, DOUGLAS REED, PAUL SCHMITT, MICHAEL STEINMETZ, DAVID E. WENG, HAROLD WERNER, JIM WOODY
DIRECTOR
NEURALTUS PHARMACEUTICALS, INC.
ARI AZHIR, ANNETTE BIANCHI, RICHARD CASEY, ANDREW GENGOS, TERRY GOULD, DONALD MCGOVERN, JOHN WALKER, JOHN WHELAN, JAMES N. WOODY
DIRECTOR
HEMAQUEST PHARMACEUTICALS, INC.
RONALD BERENSON, DANIEL CHEVALLARD, FRED DOTZLER, FREDERICK DOTZLER, BRYAN DUNNIVANT, STANDISH FLEMING, RICHARD GHALIE, PAUL GODDARD, MARK HANDFELT, MICHAEL HUANG, JOHN P. LONGENECKER, NAHEED MISFELDT, SAMUEL MURPHY, SUSAN PERRINE, ROGER POMERANTZ, WAYNE ROE, GUR ROSHWALB, IVOR ROYSTON, TAMARA SEYMOUR, ARMEN SHANAFELT, BARRY SIMON, DAVID SLACK, PATRICK SOON-SHIONG, GEORGE STAMATOYANNOPOULOS, JAMES N. WOODY
DIRECTOR
PERCEPTIMED, INC.
GRACE COLON, ROBERT E. CURRY, JOHN FRIEDMAN, ALAN JACOBS, JENNIFER JACOBS, TOM KING, THOMAS LAVIN, FRANK MAIONE, RODNEY MARKIN, HAMUTAL RUSSO, ROBERT SCHUEREN, SOMU SUBRAMANIAM
DIRECTOR
VIRACTA THERAPEUTICS, INC.
RONALD BERENSON, DANIEL CHEVALLARD, FRED DOTZLER, FREDERICK DOTZLER, BRYAN DUNNIVANT, STANDISH FLEMING, RICHARD GHALIE, PAUL GODDARD, MARK HANDFELT, MICHAEL HUANG, JOHN P. LONGENECKER, NAHEED MISFELDT, SAMUEL MURPHY, SUSAN PERRINE, ROGER POMERANTZ, WAYNE ROE, GUR ROSHWALB, IVOR ROYSTON, TAMARA SEYMOUR, ARMEN SHANAFELT, BARRY SIMON, DAVID SLACK, PATRICK SOON-SHIONG, GEORGE STAMATOYANNOPOULOS, JAMES N. WOODY
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-11-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-10-24 
2019-02-12
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-30 
2019-02-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-01-31 
2018-12-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-30 
2018-07-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-06-18 
2017-04-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-23 
2016-05-24
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-05-17 
2015-03-26
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-09-10 
2014-09-19
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-09-10 
2012-12-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2012-11-29 
2012-05-31
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-15 
2012-04-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-03-07 
2011-12-20
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-15 
2011-05-31
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-20 
2011-05-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-11 
2010-11-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-10-19 
2010-08-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-07-26 
2009-12-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-12-04 
2009-11-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-10-29 
2009-04-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-04-09